Page, Brent D. G.
Valerie, Nicholas C. K. http://orcid.org/0000-0002-9423-964X
Wright, Roni H. G.
Wallner, Olov
Isaksson, Rebecka
Carter, Megan
Rudd, Sean G. http://orcid.org/0000-0002-4368-3855
Loseva, Olga
Jemth, Ann-Sofie
Almlöf, Ingrid
Font-Mateu, Jofre
Llona-Minguez, Sabin http://orcid.org/0000-0003-3187-722X
Baranczewski, Pawel
Jeppsson, Fredrik
Homan, Evert
Almqvist, Helena
Axelsson, Hanna
Regmi, Shruti
Gustavsson, Anna-Lena
Lundbäck, Thomas
Scobie, Martin
Strömberg, Kia
Stenmark, Pål
Beato, Miguel
Helleday, Thomas
Article History
Received: 12 October 2017
Accepted: 17 November 2017
First Online: 17 January 2018
Change Date: 1 November 2019
Change Type: Correction
Change Details: An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Competing interests
: B.D.G.P., N.C.K.V., O.W., S.L.-M., M.S. and T.H. are listed as inventors on a patent describing NUDT5 inhibitors. The patent covers compound matters and is fully owned by a not-for-profit public foundation, the Helleday Foundation, that supports medical research. There is no reward scheme to inventors. The remaining authors declare no competing financial interests.